mbt

UNC 669 is an effective and specific MBT (malignant brain tumor) inhibitor with IC50 of 4.2/3.1 uM for L3MBTL1/3.

UNC1215, an effective and specific MBT (malignant brain tumor) antagonist, binds L3MBTL3 (IC50/Kd: 40/120 nM). The selectivity of UNC1215 for L3MBTL3 is 50-fold higher versus other members of the human MBT family.

DMBT is an inhibitor of invasion and metastasis through Akt/GSK-3β/β-catenin pathway in B16BL6 cells.

UNC926 (UNC-926) inhibits L3MBTL1 (IC50: 3.9 μM). UNC926 also exhibits a low micromolar affinity for L3MBTL3. UNC926 inhibits binding of the 3xMBT domain to H4K20me1. It selectively and dose-dependently inhibits the L3MBTL13xMBT-H4K20me1 interaction. UNC926 has not an effect on the binding of 53BP1 to H4K20me1.

UNC 1021 is a selective L3MBTL3 inhibitor (IC50 = 0.048 μM).

Sodium 2-mercaptobenzothiazole is the sodium salt of mercaptobenzothiazole, and is used as a copper corrosion inhibitor.

UNC1079 is an selective L3MBTL3 domain inhibitor

UNC926 hydrochloride is a methyl-lysine (Kme) reader domain inhibitor.

Methyl 2-bromo-3,3,3-trifluoropropionate (MBTFP) is a surfactant known for its excellent miscibility, making it an effective solvent in organic reactions. It demonstrates good reactivity in chemical synthesis, suitable for preparing a variety of organic compounds. Additionally, Methyl 2-bromo-3,3,3-trifluoropropionate enhances the uniformity of reaction mixtures, effectively promoting reaction processes.

4-Methylbenzothiophene (4-MBT) is classified as a polycyclic aromatic sulfur compound (PASC) with utility as a biochemical synthesis reagent.